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Deﬁciency of the a Subunit of Succinate–Coenzyme A Ligase
Causes Fatal Infantile Lactic Acidosis with Mitochondrial DNA
Depletion
Elsebet Ostergaard, Ernst Christensen, Elisabeth Kristensen, Bodil Mogensen, Morten Duno,
Eric A. Shoubridge, and Flemming Wibrand
Fatal infantile lactic acidosis is a severe metabolic disorder characterized by the onset of lactic acidosis within the 1st d
of life and early death. We found a combined respiratory-chain enzyme deﬁciency associated with mitochondrial DNA
(mtDNA) depletion in a small consanguineous family with this disorder. To identify the disease-causing gene, we per-
formed single-nucleotide polymorphism homozygosity mapping and found homozygous regions on four chromosomes.
DNA sequencing revealed a homozygous 2-bp deletion in SUCLG1, a gene that encodes the a subunit of the Krebs-cycle
enzyme succinate–coenzyme A ligase (SUCL). The mtDNA depletion is likely explained by decreased mitochondrial
nucleoside diphosphate kinase (NDPK) activity resulting from the inability of NDPK to form a complex with SUCL.
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The molecular basis of several disorders resulting from a
decrease in mtDNA copy number—the mtDNA-depletion
syndromes (MIM 251880)—has been elucidated over the
past decade. Mutations in six genes have now been re-
ported to cause mtDNA depletion in humans: TP, which
is associated with mitochondrial neurogastrointestinal
encephalopathy (MNGIE [MIM 603041])1; TK2, which
causes mitochondrial myopathy2; DGUOK, associated
with liver failure3; POLG, which can cause Alpers syn-
drome (MIM 203700)4; MPV17, which is responsible for
isolated liver mtDNA depletion5; and SUCLA2, which
causes encephalomyopathy.6
Fatal infantile lactic acidosis can be caused by various
enzyme defects—such as pyruvate dehydrogenase (PDH)
deﬁciency, pyruvate carboxylase deﬁciency, and deﬁ-
ciency of complex I of the respiratory chain—or by
mtDNA mutations. The disorder has not, however, been
reported in association with mtDNA depletion, and, in
many cases, the underlying genetic defect remains un-
known. Most cases are sporadic or occur in small families,
which usually precludes the use of linkage analysis.
We identiﬁed a small consanguineous family of Pakis-
tani origin with autosomal recessive fatal infantile lactic
acidosis (ﬁg. 1). The family gave informed consent for the
study.
Patient 1 was the ﬁrst child of ﬁrst-cousin parents. A
previous pregnancy had ended in a spontaneous abortion
at 11 wk. Patient 1 was born at 40 wk gestation, with a
birth weight of 2,150 g, a birth length of 48 cm, and a
head circumference of 32 cm. His Apgar scores were nor-
mal. He was dysmature, with hypertrichosis and low hair-
line, and he had hepatomegaly and severe hypothermia.
He was hypotonic, and, in the 1st d of life, he became
severely acidotic, with a blood pH of 6.7. He had Cheyne-
Stokes respiration and received respiratory support. Find-
ings from an electroencephalogram were severely abnor-
mal, with focal and paroxystic activity, sharp waves, and
triphasic potentials bilaterally. Results of brain ultrasound
were normal. A urine screening showed elevated levels of
lactate and pyruvate and moderately elevated excretions
of methylmalonate and methylcitrate. The patient died at
age 4 d.
Patient 2 was the youngest sister of patient 1 (the oth-
er sister, older than patient 2, is healthy). Intrauterine
growth retardation (IUGR) was suspected during the preg-
nancy. Because of her breech position, patient 2 was born
by Cesarean delivery at 36 wk gestation, with a birth
weight of 1,730 g, a length of 42.5 cm, and a head cir-
cumference of 30.5 cm. Cord blood pH and Apgar scores
were normal. In the 1st d, she developed hypoglycemia,
with blood glucose levels of 0.8–1.3mmol/liter, and severe
lactic acidosis. Results from a cerebral ultrasound were
normal. A urine screening showed severely increased ex-
cretions of lactate and pyruvate, moderately elevated ex-
cretions of methylmalonate (67.7 mmol/mmol creatinine;
reference !3.6 mmol/mmol creatinine) and methylcitrate
(169.0 mmol/mmol creatinine; reference !7.6 mmol/mmol
creatinine), and slightly elevated excretions of the Krebs-
cycle intermediates fumarate, malate, citrate, and 2-oxo-
glutarate. Plasma and urine amino acids showed highly
elevated taurine and glycine levels and moderately ele-
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Figure 1. Pedigree of the family of Pakistani origin with fatal
infantile lactic acidosis due to SUCLG1 mutations.
vated alanine and lysine levels. From age 2 d, she received
respiratory therapy. She died at age 3 d.
Patient 3 was the cousin of patients 1 and 2 and was
also born to ﬁrst-cousin parents. Five siblings are healthy.
At 35 wk gestation, IUGR was suspected on ultrasound.
She was born at 38 wk gestation, with a birth weight of
1,950 g and a birth length of 45 cm. Cord blood pH was
7.3, and Apgar scores were normal. She was dysmature,
with polydactyly, and she was hypotonic and hypother-
mic. She developed lactic acidosis, with a pH of 6.6 and
a base excess of 29.5. She received respiratory support.
A urine screening showedmassive excretions of lactic acid,
moderate excretions of pyruvate and methylmalonate,
and elevated excretions of glycine, taurine, and alanine.
She died at age 2 d. No tissue was available for analysis.
Postmortem examination of muscle (from patient 2) by
light microscopy showed normal ﬁber-type distribution
with intracellular lipid accumulation (ﬁg. 2C). No ragged-
red ﬁbers were seen. Postmortem histology of liver (from
patient 1) showed microvesicular steatosis and sinusoidal
dilatation.
Analysis of mitochondrial protein in muscle (from pa-
tient 2) and liver (from patient 1), by blue native PAGE
(BN-PAGE),7 showed a decreased amount of fully assem-
bled complexes I, III, and IV (ﬁg. 2A). The amount of
complex V was normal in muscle and increased in liver.
The amount of complex II, which is encoded only by nu-
clear genes, was normal. In both muscle and liver, a sub-
complex from complex III was seen at ∼320 kDa. BN-PAGE
of ﬁbroblast mitochondria from patient 1 showed normal
amounts of fully assembled complexes I–V (ﬁg. 2A).
In accordance with the ﬁndings of BN-PAGE, analysis
of respiratory-chain enzyme activities8,9 showed a com-
bined complex I, III, and IV deﬁciency in muscle and liver
(ﬁg. 2B). The enzyme analysis of ﬁbroblasts was normal
(results not shown).
The relative mtDNA copy number was determined by
Southern-blot analysis, as reported elsewhere.10 Southern-
blot analysis showed a decreased amount of mtDNA in
muscle (15% of normal) and a slightly decreased amount
of mtDNA in liver (63% of normal) (ﬁg. 2E). Real-time
quantitative PCR gave similar results (not shown).
To identify the disease-causing gene, DNA from patients
1 and 2 was used in a genomewide search for homozy-
gosity with the Affymetrix GeneChip 10K array, version
2.0 (Affymetrix).10 Because of the small family size, the
SNP analysis showed several homozygous regions of var-
iable sizes. Because of the close relationship between the
parents (ﬁrst cousins), the homozygous regions identical
by descent in each patient were expected to be large, ∼28
cM.11 We searched for candidate genes in homozygous
regions, arbitrarily chosen to be at least 10 Mb, that were
common to the two patients. We found four such regions,
on chromosomes 2, 3, 4, and 5 (table 1). The Mitop2 da-
tabase was used to search for genes encoding mitochon-
drial proteins in these regions. Of the 15 RefSeq genes
found, we considered the SUCLG1 gene (GenBank acces-
sion number NM_003849) on chromosome 2, which en-
codes the a subunit of the Krebs-cycle enzyme succinate–
coenzyme A (CoA) ligase (SUCL) (also termed “succinyl-
CoA synthetase” and “succinate thiokinase”), to be a can-
didate gene because of the involvement of the ATP-form-
ing b subunit of SUCL, encoded by SUCLA2, in patients
with a combined respiratory-chain deﬁciency andmtDNA
depletion in muscle,6 elevated levels of urine methylma-
lonate and methylcitrate—which was also found in pa-
tients with SUCLA2 mutations10,12—and the excretion of
Krebs-cycle metabolites in patient 2.
Sequencing of SUCLG1 (table 2) revealed a homozygous
2-bp deletion, c.113_114delAT, in exon 2 in both patients
(ﬁg. 2D). The parents and a healthy sister were hetero-
zygous for the mutation. The mutation leads to a change
of the reading frame and a premature stop codon and is
expected to lead to the synthesis of a prematurely trun-
cated protein.
A rabbit polyclonal antibody against SUCLG1 was
generated using a synthetic peptide speciﬁc to human
SUCLG1 (CGTTIYKEFEKRKML) (Rockland Immunochem-
icals). Immunoblot analysis of ﬁbroblast mitochondria
showed the complete absence of SUCLG1 protein in the
affected patients (ﬁg. 2F).
This is the ﬁrst report, to our knowledge, of mutations
in SUCLG1, which we show here to cause fatal infantile
lactic acidosis associated with mtDNA depletion. SUCL is
a dimeric enzyme that catalyzes a reversible reaction in
which succinyl-CoA and either adenosine diphosphate
(ADP) or guanosine diphosphate (GDP) are converted to
succinate and ATP or guanosine triphosphate (GTP), de-
pending on which b subunit is present (ﬁg. 3).13 The a
subunit of SUCL forms a heterodimer with either of its b
subunits encoded by SUCLA2 and SUCLG2, resulting in
an ATP/ADP–speciﬁc SUCL (A-SUCL) and a GTP/GDP–spe-
ciﬁc SUCL (G-SUCL). A-SUCL and G-SUCL are located in
the mitochondrial matrix, and it is likely that they both
catalyze substrate-level phosphorylation in the Krebs cy-
cle, although this has not been conclusively established
for G-SUCL.14 Both enzymes may also catalyze the reverse
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Figure 2. Histology and analysis of the respiratory chain and SUCLG1. A, BN-PAGE of muscle, liver, and ﬁbroblasts, showing a decreased
amount of fully assembled complexes I, III, and IV in muscle and liver in patients 1 and 2 (P1 and P2) with SUCLG1 mutations, compared
with controls (C). In addition, a subcomplex from complex III is seen (arrow). B, Enzyme analysis of the respiratory chain related to
citrate synthase (CS) shows a deﬁciency of complexes I, III, and IV in muscle (M) from patient 1 and in liver (L) from patient 2 (gray
bars). ValuesSDs for controls are shown by black bars. C, Histology of muscle and liver. ATPase staining (pH 9.4) (top) and oil red
staining (middle) of muscle showing normal ﬁber-type distribution and intracellular lipid accumulation (arrow). The tissue fragmentation
is a freeze artifact. Hematoxylin and eosin staining (bottom) of liver, showing sinusoidal dilatation (arrow) and microvesicular steatosis.
D, Mutation analysis of SUCLG1 showing the homozygous c.113_114delAT mutation in patient 1. E, Analysis of the relative mtDNA copy
number by Southern-blot analysis of muscle from patient 2 and liver from patient 1 compared with controls. The mtDNA/nuclear DNA
(nDNA) ratio is shown below the bands. F, Immunoblot analysis of ﬁbroblast mitochondria showing a complete absence of SUCLG1
protein in patients 1 and 2 compared with controls. An antibody against PDH E2 was used as a loading control.
reaction to supply succinyl-CoA for heme synthesis and
ketone-body activation.
Enzymatic assays and western- and northern-blot anal-
yses have shown that the two enzymes are widely ex-
pressed in human tissues, with G-SUCL predominantly
expressed in anabolic tissues, such as liver and kidney, and
A-SUCL in catabolic tissues, such as brain, heart, and skel-
etal muscle.13,15 The pattern of expression and activity of
the two SUCL enzymes may reﬂect the high ATP energy
demand in catabolic tissues, such as brain and muscle.
Substrate-level generation of GTPmay, on the other hand,
be more important in anabolic tissues, such as liver and
kidney, where it is used by the enzymes phosphoenol-
pyruvate carboxykinase and GTP-AMP phosphotransfer-
ase, and it is involved in various processes, such as protein
synthesis and possibly mitochondrial membrane fusion.14
What links the deﬁciency in SUCL with mtDNA deple-
tion? One strong possibility is a decrease in the activity
of nucleoside diphosphate kinase (NDPK). Immunopre-
cipitation experiments that use mitochondria from rat
liver b cells show that antiserum against SUCL coimmu-
noprecipitates NDPK.16 Further, NDPK forms a complex
with SUCL in rabbit heart mitochondria,17 and NDPK and
SUCL were shown to copurify in Pseudomonas aerugino-
sas.18 NDPKs are protein kinases that use ATP to synthesize
nonadenylic nucleoside triphosphates for nucleic acid
synthesis. A decreased activity of NDPK due to the lack of
interaction with SUCL could explain the mtDNA deple-
tion and, hence, the combined respiratory-chain enzyme
deﬁciency in muscle and liver.
The analysis of the respiratory chain in ﬁbroblasts gave
normal results, despite the absence of SUCLG1 protein. A
likely explanation is that, in replicating tissues such as
ﬁbroblasts, deoxyribonucleotide triphosphates (dNTPs)
are transported from the cytoplasm into themitochondria
via the deoxynucleotide carrier, and these tissues are there-
fore less dependent on mitochondrial NDPK activity for
the de novo synthesis of dNTPs.
Mutations were recently reported in the SUCLA2 gene,
which encodes the ATP-forming b subunit of SUCL.6 The
disorder is associated with a combined respiratory-chain
enzyme deﬁciency and mtDNA depletion in muscle, sim-
ilar to what is found in the family reported here. In pa-
tients from the Faroe Islands, we found a founder muta-
tion in SUCLA2 that causes skipping of exon 4, resulting
in the absence of functional protein.10 Despite the similar
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Table 1. Regions 110 Mb That Were Homozygous in Both Affected
Siblings
Chromosome SNPs
Interval
Size
(Mb)
No. of RefSeq
Genes
in Mitop2
2p12-q13 rs934310–rs1002016 (57 SNPs) 29.0 11
p26.3-p25.1 rs3856832–rs3846122 (80 SNPs) 13.0 3
q25-q28.3 rs1008326–rs925084 (79 SNPs) 24.0 1
5q21.3-q23.1 rs961426–rs1918159 (52 SNPs) 10.8 0
Table 2. Primers for Ampliﬁcation of SUCLG1
Exon
Primer
(5′r3′)
Forward Reverse
1 AATTTGTTCAGGCGACTGCT GGCGCCAGGAAGACAGTA
2 GCGCGTGCATTAAAGAATTT TTCTGCAACAATCATGTGTTATTT
3 GCTTTTGCTTCTCTTGGGCT CAAAGAATGCTCGCTCTTCC
4–5 TGTCCTTTTCTTACCCCAAGA GAGTTTTGAGGGTTTAAGGCA
6 TCACTCGAAGTGTTTGGTAATTT CTCATCCAATGAAGACACCAC
7 AAATTCCATGGTTCACCCTT ACTTCTGAAACAAGCCTCTGAT
8 CATGAATTTGAGGTCCCGTT CCACACACAGAGAAAGCCTG
9 TCAAACACCCTCATCCTGGT CAAACTGCTGCTGGGTTACA
NOTE.—The PCR products were sequenced with the Big Dye Ter-
minator v1.1 and were analyzed on an ABI 3130 (Applied
Biosystems).
Figure 3. The Krebs cycle and methylmalonate metabolism.
CoASH p coenzyme A. Pi p inorganic phosphate.
ﬁndings—that is, a combined oxidative phosphorylation
deﬁciency and mtDNA depletion—patients with SUCLA2
and SUCLG1 mutations differ markedly in their clinical
presentations. The patients with SUCLG1 mutations had
an extremely severe phenotype with antenatal manifes-
tations of the disorder—severe lactic acidosis in the 1st d
of life and death within 2–4 d. The phenotypes of patients
with SUCLA2 mutations were milder; these patients were
generally healthy at birth but presented with severe hy-
potonia and muscle weakness at age 3–6 mo. Subse-
quently, they developed a Leigh-like disorder with hearing
impairment and dystonia, and they had a life span of up
to 21 years. The much more severe disorder in patients
with SUCLG1 mutations is likely caused by the complete
absence of both A-SUCL and G-SUCL, whereas the milder
phenotype of patients with SUCLA2 mutations may be
explained by the presence of functional G-SUCL. In ad-
dition, in patients with SUCLA2mutations, no liver symp-
toms have been reported, which may be explained by the
relatively low expression of SUCLA2 and the high expres-
sion of SUCLG2 in liver tissue.
One of the reasons we considered SUCLG1 a candidate
gene was the excretion of methylmalonate and methyl-
citrate in our patients, similar to that found in patients
with SUCLA2 mutations. Both methylmalonyl-CoA mu-
tase and methylmalonyl-CoA racemase are reversible en-
zymes, and, therefore, accumulation of succinyl-CoA due
to a deﬁciency of succinate-CoA ligase can lead to an in-
creased concentration of D-methylmalonyl-CoA (ﬁg. 3).
An enzyme capable of hydrolyzing D-methylmalonyl-CoA
to methymalonate and CoA—the methylmalonyl-CoA
hydrolase—has been described elsewhere,19 whichmay ex-
plain the elevated free methylmalonate found in body
ﬂuids of SUCL-deﬁcient patients.
This study demonstrates the power of using homozy-
gosity mapping to identify disease-causing genes. The
method may be applied even in small consanguineous
families, provided that one has some knowledge of the
function or localization of the gene product. In this case,
although the candidate regions altogether comprised ∼77
Mb, the number of candidate genes could be limited to
15 because of the assumed mitochondrial localization.
Both the a subunit and the ATP-forming b subunit of
SUCL have now been shown to cause respiratory-chain
disorders with mtDNA depletion, and therefore SUCLG2,
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which encodes the GTP-forming b subunit, should be con-
sidered a candidate gene for other mtDNA-depletion dis-
orders, especially of the liver, because of the high expres-
sion of this subunit in liver.
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